Morepen Laboratories Stock Screener | Share Price & Fundamental Analysis
MOREPENLAB
Pharmaceuticals
Screen Morepen Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹41.26
▼
-0.77 (-1.83%)
Share Price BSE
₹41.28
▼
-0.71 (-1.69%)
Market Cap
₹2,303.05 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.88
EPS (TTM)
₹2.20
Dividend Yield
0.49%
Debt to Equity
0.07
52W High
₹75.48
52W Low
₹38.68
Operating Margin
7.00%
Profit Margin
9.28%
Revenue (TTM)
₹442.00
EBITDA
₹61.00
Net Income
₹41.00
Total Assets
₹1,778.00
Total Equity
₹1,187.00
Morepen Laboratories Share Price History - Stock Screener Chart
Screen MOREPENLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Morepen Laboratories Company Profile - Fundamental Screener
Screen Morepen Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MOREPENLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE083A01026
Morepen Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen MOREPENLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,778 | 1,293 | 1,111 | 1,070 | 858 | 664 | 615 | 586 | 538 | 524 |
| Current Assets | 1,159 | 889 | 756 | 734 | 527 | 372 | 300 | 243 | 192 | 157 |
| Fixed Assets | 489 | 307 | 267 | 252 | 225 | 216 | 236 | 264 | 272 | 297 |
| Liabilities | ||||||||||
| Total Liabilities | 1,778 | 1,293 | 1,111 | 1,070 | 858 | 664 | 615 | 586 | 538 | 524 |
| Current Liabilities | 91 | 44 | 37 | 36 | 30 | 28 | 23 | 20 | 18 | 58 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,187 | 847 | 752 | 578 | 424 | 284 | 253 | 226 | 196 | 300 |
| Share Capital | 110 | 102 | 102 | 96 | 90 | 90 | 90 | 90 | 90 | 210 |
| Reserves & Surplus | 1,047 | 745 | 651 | 457 | 291 | 194 | 163 | 136 | 106 | 91 |
Screen MOREPENLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 442 | 430 | 471 | 458 | 443 | 459 | 427 | 449 | 425 | 404 | 367 | 350 | 404 | 303 | 372 |
| Expenses | 381 | 401 | 424 | 417 | 394 | 404 | 375 | 394 | 388 | 375 | 348 | 328 | 374 | 288 | 350 |
| EBITDA | 61 | 29 | 47 | 42 | 49 | 55 | 53 | 55 | 37 | 29 | 19 | 22 | 30 | 16 | 22 |
| Operating Profit % | 7.00% | 6.00% | 9.00% | 8.00% | 10.00% | 11.00% | 11.00% | 11.00% | 8.00% | 7.00% | 4.00% | 6.00% | 7.00% | 5.00% | 5.00% |
| Depreciation | 11 | 9 | 17 | 5 | 2 | 6 | 10 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 |
| Interest | 4 | 4 | 5 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 1 |
| Profit Before Tax | 46 | 16 | 26 | 35 | 46 | 48 | 42 | 44 | 29 | 21 | 11 | 14 | 22 | 8 | 14 |
| Tax | 5 | 4 | 5 | 9 | 11 | 12 | 14 | 12 | 7 | 6 | 3 | 5 | 7 | 3 | 2 |
| Net Profit | 41 | 11 | 20 | 27 | 35 | 36 | 29 | 32 | 21 | 15 | 8 | 9 | 16 | 6 | 12 |
| EPS | 0.75 | 0.20 | 0.35 | 0.49 | 0.65 | 0.71 | 0.54 | 0.63 | 0.42 | 0.29 | 0.16 | 0.15 | 0.33 | 0.12 | 0.27 |
Morepen Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen MOREPENLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 32 | 73 | -91 | -60 | 51 | 11 | 17 | 63 | 41 | 50 |
| Investing Activities | -322 | -83 | -47 | -32 | -70 | -13 | -13 | -27 | -14 | -27 |
| Financing Activities | 300 | 5 | 144 | 66 | 47 | 6 | 0 | -38 | -24 | -27 |
| Net Cash Flow | 10 | -5 | 6 | -26 | 28 | 4 | 4 | -1 | 3 | -5 |
Screen MOREPENLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Aug | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% | 38.22% | 38.22% |
| FII Holding | 1.62% | 1.72% | 1.94% | 2.22% | 2.08% | 7.72% | 1.67% | 1.85% |
| DII Holding | 1.50% | 1.51% | 1.67% | 1.64% | 1.70% | 2.90% | 2.15% | 2.15% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 49.96% | 49.35% | 48.76% | 48.35% | 48.16% | 41.89% | 45.22% | 45.03% |
| Other Holding | 11.26% | 11.76% | 11.96% | 12.12% | 12.41% | 11.83% | 12.74% | 12.74% |
| Shareholder Count | 461,853 | 461,180 | 468,860 | 448,361 | 430,929 | 352,839 | 348,766 | 336,019 |
Morepen Laboratories Dividend Screener - Share Yield Analysis
Screen MOREPENLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.20 | 0.49% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Morepen Laboratories Index Membership - Market Screener Classification
Screen MOREPENLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Morepen Laboratories Market Events Screener - Corporate Actions
Screen MOREPENLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -9.94% | ||
| Annual General Meeting | NA | -12.82% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -1.79% |
| 2025-08-29 | 2025-08-30 | Dividend | ₹ 0.20 /share | -17.00% |
| 2025-08-06 | 2025-08-06 | Quarterly Result Announcement | NA | -3.23% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -5.11% |
| 2025-02-10 | 2025-02-10 | Extraordinary General Meeting | NA | -10.10% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 3.02% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 1.20% |
| 2024-03-18 | 2024-03-18 | Extraordinary General Meeting | NA | -21.28% |
| 2023-02-02 | 2023-02-02 | Change Of Name | NA | 0.00% |
Morepen Laboratories Competitors Screener - Peer Comparison
Screen MOREPENLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 414,605 | 39.37 | 54,729 | 9.71% | 10,980 | 42.10 |
| Divis Laboratories | 169,701 | 67.76 | 9,712 | 18.67% | 2,191 | 48.20 |
| Torrent Pharmaceuticals | 131,496 | 60.85 | 11,539 | 6.99% | 1,911 | 67.66 |
| Cipla | 122,103 | 22.30 | 28,410 | 7.12% | 5,291 | 51.10 |
| Dr Reddys Laboratories | 104,838 | 18.24 | 33,741 | 16.73% | 5,725 | 45.31 |
| Lupin | 96,170 | 22.10 | 22,910 | 13.74% | 3,306 | 56.06 |
| Zydus Life Science | 92,262 | 18.30 | 23,511 | 18.55% | 4,615 | 45.37 |
| Mankind Pharma | 90,929 | 50.34 | 12,744 | 20.90% | 2,007 | 50.55 |
| Aurobindo Pharma | 70,591 | 20.25 | 32,346 | 9.43% | 3,484 | 56.45 |
| Alkem Laboratories | 66,867 | 27.11 | 13,458 | 3.70% | 2,216 | 50.91 |
Morepen Laboratories Company Announcements - News Screener
Screen MOREPENLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-04 | Closure of Trading Window | View |
| 2025-12-04 | Disclosure Under Regulation 30 (LODR) | View |
| 2025-12-01 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-14 | Q2 FY26 Financial Results | View |
| 2025-11-14 | Board Meeting Outcome for Board Meeting Outcome Q2 FY26 Financial Results | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | View |
| 2025-11-07 | Board Meeting Intimation for Q-2 FY26 Results | View |
| 2025-11-06 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window | View |
| 2025-10-13 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window | View |
| 2025-10-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-23 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window | View |
| 2025-09-20 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-09-08 | Execution Of Joint Venture Agreement | View |
| 2025-09-08 | Formation Of To Be Incorporated Joint Venture Company | View |
| 2025-09-08 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-09-06 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |